Brought to you by 
Tandem Diabetes Care nets $128.3mm in IPO
12 Feb 2018
Executive Summary
Device firm Tandem Diabetes Care Inc. netted $128.3mm in its initial public offering of 9.2mm common shares (including the overallotment) at $15 each. The company planned to sell up to 7.1mm shares between $13 and $15.
Deal Industry
- Medical Devices
-
Pharmaceuticals
- Drug Delivery
-
Medical Devices
- Monitoring Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Tandem Diabetes Care nets $128.3mm in IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice